VALIDATED STABILITY INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE QUANTIFICATION OF ASENAPINE MALEATE
Keywords:
Antipsychotic drug, Stress degradation, High performance liquid chromatography, QuantificationAbstract
Objective: A stability indicating high performance liquid chromatography method using the photodiode array detector is developed and validated for the analysis of asenapine in bulk and in its tablet formulation.
Methods: The method utilized a BDS Y Persil C18 (250 x 4.6 mm, 5 µm) column with 0.1% orthophosphoric acid and methanol (65:35 v/v) as mobile phase. The analysis was performed at 30 oC column temperature with a flow rate of 1 ml/min and detection at 227 nm. The method was validated for specificity, sensitivity, precision, linearity, accuracy and robustness. Asenapine was subjected to stress degradation studies under acidic, basic, oxidative, thermal and photolytic conditions.
Results: Under optimized experimental conditions, asenapine was eluted from the column at a retention time of 6.781 min. The method was linear in the range of 100-300 µg/ml. The linear regression data showed good relationship (correlation coefficient (R2) = 0.9999). The relative standard deviation and mean recovery values were within limits. The analytical performance of the method was not affected when small variations in the experimental parameters were made. Degradation products resulting from stress degradation studies did not interfere with the detection of asenapine.
Conclusion: The proposed stability indicting high performance liquid chromatography method is sensitive, precise, accurate, robust and specific. This method can be used for quantification of asenapine in bulk drug and in tablet dosage form in the presence of its stress degradation products.
Downloads
References
Tarazi FI, Shahid M. Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania. Drugs Today 2009;45:865-76.
Stoner SC, Pace HA. Asenapine: a clinical review of a second-generation antipsychotic. Clin Ther 2012;34:1023-40.
Citrome L. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic. Int J Clin Pract 2009;63:1762-84.
Mrudulesh Y, Ravi Sankar P, Devadasu CH, Srinivasa Babu P. Development of a validated UV spectrophotometric method for the quantitative estimation of asenapine maleate in bulk drug. J Chem Pharm Sci 2013;6:227-30.
Halima OA, Aneesh TP, Reshma G, Thomas NR. Development and validation of UV spectrophotometric method for the estimation of asenapine maleate in bulk and pharmaceutical formulation. Der Pharm Chem 2012;4:644-9.
Surekha ML, Swapna M, Swamy GK. New validated visible spectrophotometric methods for the estimation of triptans and asenapine maleate in bulk and in pharmaceutical dosage forms. Indo Am J Pharm Res 2013;3:4637-44.
Nagarajan G, Shirisha K, Archana M, Sravanthi P, Ramana BV. Method development and validation of RP-HPLC method for determination of new antipsychotic agent asenapine maleate in bulk and in pharmaceutical formulation. Der Pharm Lett 2012;4:1805-10.
Geetharam Y, Ramamohan GV, Praveen srikumar P, Rusyendra GV, Lavanya N. Development and validation of RP-HPLC method for the estimation of asenapine maleate in bulk and pharmaceutical dosage forms. Asian J Pharm Anal Med Chem 2013;1:132-9.
Parthasarathi TR, Srinivas TS, Vanitha Sri M, Sai Ram S, Basha MM, Rajesh P. Quantitative determination of asenapine maleate using reverse phase-high performance liquid chromatography. Int J Pharma Bio Sci 2012;3:360-6.
Kiran A, Manish Kumar T, Raghunandan N, Shilpa A. Method development and validation of asenapine in bulk by RP-HPLC method. J Biochem Pharmacol Res 2012;4:2580-4.
De Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H. Quantification of asenapine and three metabolites in human plasma using liquid chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects. Biomed Chromatogr 2012;26:156-65.
de Boer T, Meulman E, Meijering H, Wieling J, Dogterom P, Lass H. Development and validation of automated SPE-HPLC-MS/MS methods for the quantification of asenapine, a new antipsychotic agent, and its two major metabolites in human urine. Biomed Chromatogr 2012;26:1461-3.
Caitlin M, Oscar P, Dan A, Diane MM, Norman W. Asenapine (Saphrisw): GC–MS method validation and the postmortem distribution of a new atypical antipsychotic medication. J Anal Toxicol 2013;37:559–64.
Chhalotiya UK, Bhatt KK, Shah DS, Patel JR. Stability-Indicating liquid chromatographic method for the quantification of the new antipsychotic agent asenapine in bulk and in pharmaceutical formulation. Sci Pharm 2012;80:407–17.
Narke R, Mandlik S, Kapure S. Bioanalytical development and validation of Stability indicating RP-HPLC method for the estimation of asenapine maleate in plasma. Inventi Impact: Biomed Anal 2015;2015:5-8.
Aneesh TP, Rajasekaran A. Stress degradation studies and development and validation of RP-HPLC method for the estimation of asenapine maleate. Int J Pharm Pharm Sci 2012;4:448-57.
International Conference on Harmonization, ICH Guidelines, Validation of Analytical Procedures Technical Requirements for Registration of Pharmaceuticals for Human Use: Text and Methodology Q 2 (R1), International Conference on Harmonization, Geneva, Switzerland; 2005.